CYBN

Cybin Inc.

0.35 USD
-0.00 (-0.83%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Cybin Inc. stock is down -6.19% since 30 days ago. The next earnings date is Jun 25, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 40% of the previous 4 May’s closed higher than April. 100% of analysts rate it a buy.

About Cybin Inc.

Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders. It has also developed EMBARK, a psychedelic-assisted psychotherapy.